Sign in
Taking peopleNo phase

Memory Support System for people with mild cognitive impairment and their partners

Tests a memory support program for people with mild cognitive impairment and partners.

Key facts

Who runs it
Bruyère Health Research Institute.
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Memory Support System Feasibility Study
Status
Recruiting
People taking part
40 people, planned
Started
17 Dec 2023
Expected to end
30 Apr 2027
Type of study
Interventional
Treatments tested
  • Memory Support System
Record updated
25 September 2026

Who can take part

The trial is looking for people with mild cognitive impairment (MCI), a mild memory or thinking problem, and their care partners. They will try the Memory Support System, a memory training program.

Age
50 years and older.
Sex
All sexes can join.
Disease stage
Diagnosis of single or multi-domain MCI. Clinical Dementia Rating global (CDR) score of ≤ 0.5. Montreal Cognitive Assessment score of ≥18.
Earlier treatment
People must take no nootropic (memory-boosting) drugs, or a stable amount of them, for ≥ 3 months.
Main reasons for not taking part
  • Sight or hearing problems that would get in the way of the program training.
  • Past reading or writing problems that would get in the way of the program training.
  • Taking part in another related clinical trial at the same time.
  • No contact with a care partner at least 2 times a week.
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • diagnosis of single or multi-domain MCI
  • Clinical Dementia Rating global (CDR) score of ≤ 0.5
  • Montreal Cognitive Assessment score of ≥18
  • available contact with a care partner ≥ 2 times weekly
  • absence or stable intake of nootropic(s) for ≥ 3 months

Who cannot take part

  • concurrent participation in another related clinical trial
  • visual/hearing impairment and/or history of reading or written inability/disability sufficient to interfere with MSS training

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Mild cognitive impairment

This trial is currently available in Canada.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to determining the feasibility of providing the Memory Support System (MSS) to individuals with mild cognitive impairment (MCI) and their partners at a clinic in Ontario, Canada. This will involve a) collecting information from patients referred to the a memory clinic and geriatric day hospital about the patient's interest in and the patient's preferred method to administer the MSS; and b) a cost analysis related to implementation of the MSS. The study will also measure efficacy outcomes of the MSS regarding program adherence as well as to self-reported IADLs, self-efficacy for memory, quality of life, mood, anxiety, and caregiver burden among a sample of individuals with MCI and their care partners

The group in the trial

  • Memory Support System participantsTreatment being tested

    Treatment: Memory Support System

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Implementation of the Memory Support System: A Feasibility Study
Plain-language title
Memory Support System for people with mild cognitive impairment and their partnersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT05999929, who can take part
Record updated
25 September 2026